DJ Sartorius Stedim Biotech: Information on Document Availability Sartorius Stedim Biotech SA Sartorius Stedim Biotech: Information on Document Availability 16-Feb-2024 / 09:23 CET/CEST Dissemination ...

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023 12-Oct-2023 / 21:05 CET/CEST Dissemination of a French Regulatory News ...

Sartorius Stedim revenue comes to 100% from the BPS division, while Sartorius AGs revenue is split 80/20 between BPS/LPS. Capital reinvestment. Over the long term, ...

Regulatory News: Sartorius Stedim Biotech (SSB) (Paris:DIM) has agreed to acquire parts of Danaher’s Life Science portfolio as part of a broader trans ...

Sartorius Stedim Biotech agreed to buy Polyplus, a maker of components for cell and gene therapies, for about €2.4 billion ($2.6 billion) from a group of private investors.

Despite initial signs of recovery towards the end of the third quarter, longer-than-expected soft demand continued to impact the business development of Sartorius Stedim Biotech in the first nine ...

AUBAGNE, France, April 30, 2020/ PRNewswire/-- Sartorius Stedim Biotech, a leading partner of the biopharma industry, successfully closed the acquisition of selected life science businesses of ...

Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Information on Document Availability 17-Feb-2025 / 10:56 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The ...